Tag: CSE:CBII

June 6, 2019

Pharmacists Take Center Stage in a Mature Medical Cannabis Market

In most countries with a mature medical cannabis market, pharmacists are at the center of an industry going mainstream.
May 30, 2019

CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019

CB2 Insights (CSE:CBII, OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company focused on mainstreaming medical cannabis to the healthcare industry...
May 27, 2019

CB2 Insights to Host Q12019 Earnings Call on May 31, 2019

CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading provider of medical cannabis-focused Real World Evidence to the healthcare...
May 17, 2019

CB2 Insights Announces Ticker Symbol Change on OTCQB

CB2 Insights (CSE:CBII) (OTCQB:CBIIF) a leading technology company focused on mainstreaming medical cannabis to the healthcare industry through Real-World Evidence,...
May 2, 2019

CB2 Insights Expands Board with Teladoc Executive Marc Adelson, Appoints David Danziger as Chairman and Adopts Advance Notice Bylaw

Leading Telemedicine Firm’s Deputy Chief Legal Officer Joins Board Increasing Healthcare Technology Expertise
April 30, 2019

CB2 Insights Announces FY2018 Financial Results After Transformative Year

CB2 Insights to Host Conference Call Wednesday, May 1 at 4pm Eastern
April 26, 2019

CB2 Insights to Host FY2018 Earnings Call on May 1, 2019

CB2 Insights (CSE:CBII), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its...